หน้าแรก
ค้นหา
Experimental Alzheimer's drug shows benefits in phase 3 trial
There's a new glimmer for hope in the fight against Alzheimer's.
แสดงข้อมูลเพิ่มเติม 1
Experimental Alzheimer's drug shows benefits in phase 3 trial
Lilly drug slows Alzheimer's progression by 35% in trial
Alzheimer's clinical trial drug yields negative result
Success of experimental Alzheimer’s drug hailed as ‘historic moment’
Lecanemab: Breakthrough Alzheimer drug?
Experimental Alzheimer's drug slowed cognitive decline in clinical trial
WRAP Info Sessions 2020 | Part 3: Recent Advances in Alzheimer's Research | Sterling Johnson, PhD
Eli Lilly Alzheimer’s drug could slow disease, but comes with side effects
New Alzheimer's drug testing happening locally
Alzheimer's Disease Fast Facts
RA/TV Episode 25
Experimental heart failure drug could help millions
Phase I trial of NK cell therapy in advanced Alzheimer’s disease
Takeaway: Alzheimer early detection
What's Alzheimer's and Why Did Pfizer Hide ENBREL? // "Right to Try" is Law // Links Below
The Quantum Secret of Sleep: What Happens to Your Brain at Night?
Genis Ona: Safety and Benefits of the Placebo Effect in Microdosing | MAPS Canada Journal Club
Oral Testimony to the FDA Advisory Committee on the Approval of tofersen
Roche arthritis drug reduces Covid deaths: Oxford study
Clinical Trials and Research News Weekly Roundup | 02-17-2020 S2 E07
